NTRA:NASDAQ
Natera Inc
$410.35
arrow_upward
+0.46%(+1.88) 1D
$410.35
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 2, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NTRA...
Open
$409.40
High
$413.36
Low
$401.00
Mkt. cap
59.15B
Avg. vol.
1.47M
Volume
2.16M
52-wk high
$427.47
52-wk low
$160.59
EPS
-$1.37
Beta
1.50
Shares outstanding
144.14M
No. of employees
6K
Open
$409.40
High
$413.36
Low
$401.00
Mkt. cap
59.15B
Avg. vol.
1.47M
Volume
2.16M
52-wk high
$427.47
52-wk low
$160.59
EPS
-$1.37
Beta
1.50
Shares outstanding
144.14M
No. of employees
6K
News stories
From web sources and news partners
GuruFocus
·
1 hour ago
Natera (NTRA) CEO and President Steven Chapman Sells 1,273 Shares
Investing.com
·
2 hours ago
Natera president Solomon Moshkevich sells $1.24m in shares
Investing.com Canada
·
2 hours ago
Form 4 Natera Inc For: 2 October By Investing.com
Stock Titan
·
4 hours ago
Natera (NTRA) clinical diagnostics president sells 3,000 shares under a trading plan.
Profile
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
About Natera Inc
CEOSteven Chapman
Employees6.14K
FoundedJan 1, 2004
HeadquartersAustin, Texas, United States
SectorBiotechnology
Websitenatera.com